Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma

Clinical trial NCT00921531 · UNKNOWN

Trial details

NCT number: NCT00921531
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2009-06-01
Primary completion: 2012-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.